Kura Oncology, Inc.
KURAAs of the close on Sep 25, 2026
Price
$10.76
Market cap
$957M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$3.37
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Kura Oncology, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 11 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| HRT FINANCIAL LP | 2026-03-31 | 449,024 | Not shown | SEC filing |
| SIGNATUREFD, LLC | 2026-03-31 | 2,238 | $18.2K | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 425 | $3.46K | SEC filing |
| Parallel Advisors, LLC | 2026-03-31 | 513 | $4.17K | SEC filing |
| State of Wyoming | 2026-03-31 | 13,447 | $109K | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 217 | $1.76K | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 49,816 | Not shown | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 690,817 | $5.62M | SEC filing |
| Cedar Mountain Advisors, LLC | 2026-03-31 | 542 | $4.41K | SEC filing |
| Larson Financial Group LLC | 2026-03-31 | 36 | $293 | SEC filing |
| Advisory Services Network, LLC | 2026-03-31 | 14 | $114 | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 10,262 | $83.4K | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 95,317 | $775K | SEC filing |
| GREAT LAKES ADVISORS, LLC | 2026-03-31 | 339,599 | $2.76M | SEC filing |
| ARMISTICE CAPITAL, LLC | 2026-03-31 | 3,736,000 | $30.4M | SEC filing |
| SEI INVESTMENTS CO | 2026-03-31 | 319,266 | $2.6M | SEC filing |
| State of New Jersey Common Pension Fund D | 2026-03-31 | 25,278 | $206K | SEC filing |
| DEUTSCHE BANK AG\ | 2026-03-31 | 88,739 | $721K | SEC filing |
| Smartleaf Asset Management LLC | 2026-03-31 | 345 | $2.67K | SEC filing |
| Rosalind Advisors, Inc. | 2026-03-31 | 100,000 | $813K | SEC filing |
- Each value is checked against Kura Oncology, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Kura Oncology, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Kura Oncology, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-18 · Leoni Mollie: Larger than 79 of the 82 other insider sales of Common Stock on file. SEC filing
- 2025-12-18 · Burrows Francis: Larger than 75 of the 82 other insider sales of Common Stock on file. SEC filing
- 2025-09-29 · WILSON TROY EDWARD: Larger than 76 of the 82 other insider sales of Common Stock on file. SEC filing
- 2025-03-21 · Hasnain Faheem: Larger than 74 of the 82 other insider sales of Common Stock on file. SEC filing
- 2024-01-24 · WILSON TROY EDWARD: Larger than 78 of the 82 other insider sales of Common Stock on file. SEC filing
- 2020-10-08 · WILSON TROY EDWARD: Larger than all 82 other insider sales of Common Stock on file. SEC filing
- 2020-10-08 · WILSON TROY EDWARD: Larger than 77 of the 82 other insider sales of Common Stock on file. SEC filing
- 2020-10-07 · WILSON TROY EDWARD: Larger than 81 of the 82 other insider sales of Common Stock on file. SEC filing
- 2020-09-14 · WILSON TROY EDWARD: Larger than 80 of the 82 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-18 | Leoni Mollie · Chief Medical Officer | Common Stock | S — Open market or private sale | −84,929 | 9.82 | SEC filing |
| 2026-05-21 | Powl Brian T. · Chief Commercial Officer | Common Stock | S — Open market or private sale | −10,000 | 11.00 | SEC filing |
| 2026-05-19 | Powl Brian T. · Chief Commercial Officer | Common Stock | S — Open market or private sale | −339 | 9.21 | SEC filing |
| 2026-05-19 | FORD KATHLEEN · Chief Operating Officer | Common Stock | S — Open market or private sale | −2,257 | 9.08 | SEC filing |
| 2026-05-18 | Bair Teresa Brophy · Chief Legal Officer | Common Stock | S — Open market or private sale | −2,256 | 9.38 | SEC filing |
| 2026-01-27 | Leoni Mollie · Chief Medical Officer | Common Stock | S — Open market or private sale | −2,233 | 8.46 | SEC filing |
| 2026-01-27 | Powl Brian T. · Chief Commercial Officer | Common Stock | S — Open market or private sale | −4,842 | 8.46 | SEC filing |
| 2026-01-27 | Powl Brian T. · Chief Commercial Officer | Common Stock | S — Open market or private sale | −1,572 | 8.46 | SEC filing |
Showing 8 of 14 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-04 | Hasnain Faheem · Director | Option to purchase common stock | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-04 | Collins Helen Louise · Director | Option to purchase common stock | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-04 | Malley Thomas · Director | Option to purchase common stock | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-04 | Parks Diane L. · Director | Option to purchase common stock | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-04 | SCHAFER CAROL · Director | Option to purchase common stock | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-04 | VASCONCELLES MICHAEL · Director | Option to purchase common stock | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-06-04 | Szela Mary T · Director | Option to purchase common stock | A — Grant, award, or other acquisition | +35,000 | SEC filing |
| 2026-03-23 | WILSON TROY EDWARD · President and CEO | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | +6,103 | SEC filing |
Showing 8 of 22 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-06-02 | WILSON TROY EDWARD · President and CEO | Common Stock | J — Other acquisition or disposition | −41,318 | SEC filing |
| 2023-06-02 | WILSON TROY EDWARD · President and CEO | Common Stock | J — Other acquisition or disposition | +8,394 | SEC filing |
| 2023-06-02 | WILSON TROY EDWARD · President and CEO | Common Stock | J — Other acquisition or disposition | −8,394 | SEC filing |
| 2023-06-02 | WILSON TROY EDWARD · President and CEO | Common Stock | J — Other acquisition or disposition | −212,500 | SEC filing |
| 2023-06-02 | WILSON TROY EDWARD · President and CEO | Common Stock | J — Other acquisition or disposition | +300,000 | SEC filing |
| 2023-06-02 | WILSON TROY EDWARD · President and CEO | Common Stock | J — Other acquisition or disposition | −27,966 | SEC filing |
| 2023-06-02 | WILSON TROY EDWARD · President and CEO | Common Stock | J — Other acquisition or disposition | −300,000 | SEC filing |
| 2022-10-06 | WILSON TROY EDWARD · President and CEO | Common Stock | J — Other acquisition or disposition | +1,084,300 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.